Dimensional Fund Advisors
APTO

Dimensional Fund Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

Dimensional Fund Advisors’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$41K Hold
152
– – ﹤0.01% 3428
2022
Q2 		$51K Hold
152
– – ﹤0.01% 3386
2022
Q1 		$93K Hold
152
– – ﹤0.01% 3400
2021
Q4 		$92K Hold
152
– – ﹤0.01% 3446
2021
Q3 		$149K Buy
+152
New +$190K ﹤0.01% 3383

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $733M AUM 11.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 35.16% 1-Year Est. Return

Dimensional Fund Advisors's APTO Position: Q3 2022 in Review

Dimensional Fund Advisors held its Aptose Biosciences, Inc. (APTO) position steady in Q3 2022 at 152 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #3428.

Dimensional Fund Advisors first reported a position in APTO in Q3 2021 and has held it in 5 quarters since. The position peaked at $149K in Q3 2021. 49 funds tracked by Wall St. Rank hold APTO as of Q3 2022.

  • Dimensional Fund Advisors held 152 shares of Aptose Biosciences, Inc. worth $41K as of Q3 2022.
  • Dimensional Fund Advisors left its Aptose Biosciences, Inc. share count unchanged in Q3 2022.
  • Aptose Biosciences, Inc. made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3428 holding.
  • Dimensional Fund Advisors first reported a position in Aptose Biosciences, Inc. in Q3 2021 and has held it in 5 quarters since.
  • Dimensional Fund Advisors's Aptose Biosciences, Inc. position peaked at $149K in Q3 2021.
  • 49 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.